Carregant...
Identifying therapeutic targets for schizophrenia
There is a continual need to develop new therapies for neuropsychiatric disorders such as Schizophrenia, and identifying the underlying molecular processes remains challenging. Chadha et al. recently discovered a potential role for mTOR kinase activity disruption in Schizophrenia and further uncover...
Guardat en:
| Publicat a: | Commun Biol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8192517/ https://ncbi.nlm.nih.gov/pubmed/34112930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-021-02270-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|